Brain mu-opioid receptor binding: relationship to relapse to cocaine use after monitored abstinence
- 2 September 2008
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 200 (4) , 475-486
- https://doi.org/10.1007/s00213-008-1225-5
Abstract
Cocaine users have increased regional brain mu-opioid receptor (mOR) binding which correlates with cocaine craving. The relationship of mOR binding to relapse is unknown. To evaluate regional brain mOR binding as a predictor of relapse to cocaine use is the objective of the study. Fifteen nontreatment-seeking, adult cocaine users were housed on a closed research ward for 12 weeks of monitored abstinence and then followed for up to 1 year after discharge. Regional brain mOR binding was measured after 1 and 12 weeks using positron emission tomography (PET) with [11C]carfentanil (a selective mOR agonist). Time to first cocaine use (lapse) and to first two consecutive days of cocaine use (relapse) after discharge was based on self-report and urine toxicology. A shorter interval before relapse was associated with increased mOR binding in frontal and temporal cortical regions at 1 and 12 weeks of abstinence (Ps < 0.001) and with a lesser decrease in binding between 1 and 12 weeks (Ps < 0.0008). There were significant positive correlations between mOR binding at 12 weeks and percent days of cocaine use during first month after relapse (Ps < 0.002). In multiple linear regression analysis, mOR binding contributed significantly to the prediction of time to relapse (R 2 = 0.79, P < 0.001), even after accounting for clinical variables. Increased brain mOR binding in frontal and temporal cortical regions is a significant independent predictor of time to relapse to cocaine use, suggesting an important role for the brain endogenous opioid system in cocaine addiction.Keywords
This publication has 63 references indexed in Scilit:
- Cue-Induced Brain Activity Changes and Relapse in Cocaine-Dependent PatientsNeuropsychopharmacology, 2005
- Biological markers of cocaine addiction: implications for medications developmentAddiction Biology, 2003
- Quantification of brain μ-opioid receptors with [11C]carfentanil: reference-tissue methodsNuclear Medicine and Biology, 2003
- Carbamazepine in the treatment of cocaine dependence: Subtyping by affective disorder.Experimental and Clinical Psychopharmacology, 2002
- The validity of self-reported cocaine use in two groups of cocaine abusers.Journal of Consulting and Clinical Psychology, 1999
- Daily Cocaine Use Patterns:Journal of Addictive Diseases, 1996
- Adaptive changes in the proenkephalin and D2 dopamine receptor mRNA expression after chronic cocaine in the nucleus accumbens and striatum of the ratEuropean Neuropsychopharmacology, 1995
- Repeated cocaine administration upregulates K and μ, but not δ, opioid receptorsNeuroReport, 1994
- Chronic cocaine alters brain mu opioid receptorsBrain Research, 1992
- Cocaine alters opiate receptor binding in critical brain reward regionsSynapse, 1989